Article Text

other Versions

PDF

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. An under recognised spectrum of disease
  1. Susan J Davies (susanjdavies{at}doctors.org.uk)
  1. Royal Brompton and Harefield Hospitals NHS Trust, United Kingdom
    1. John R Gosney (j.gosney{at}rlbuht.nhs.uk)
    1. Royal Liverpool University Hospital, United Kingdom
      1. David M Hansell (d.hansell{at}rbh.nthames.nhs.uk)
      1. Royal Brompton and Harefield Hospitals NHS Trust, United Kingdom
        1. Athol U Wells (a.wells{at}rbh.nthames.nhs.uk)
        1. Royal Brompton and Harefield Hospitals NHS Trust, United Kingdom
          1. Ron du Bois (r.dubois{at}rbh.nthames.nhs.uk)
          1. Royal Brompton and Harefield Hospitals NHS Trust, United Kingdom
            1. Margaret M Burke (m.burke{at}rbht.nhs.uk)
            1. Royal Brompton and Harefield Hospitals NHS Trust, United Kingdom
              1. Mary N Sheppard (m.sheppard{at}rbh.nthames.nhs.uk)
              1. Royal Brompton and Harefield Hospitals NHS Trust, United Kingdom
                1. Andrew Gordon Nicholson (a.nicholson{at}rbht.nhs.uk)
                1. Royal Brompton and Harefield Hospitals NHS Trust, United Kingdom

                  Abstract

                  This study reviews 19 patients diagnosed with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) between 1992 and 2006. Most patients were female (n=15) and non-smokers (n=16). Clinical presentation was either with symptomatic pulmonary disease (Group 1) (n=9) or as an incidental finding during investigation for another disorder, most frequently malignant disease (Group 2) (n=10). In Group 1, cough and dyspnoea were the most frequent symptoms, with an average duration of 8.6 years before diagnosis. Both groups showed mainly stable disease without treatment, although one patient progressed to severe airflow obstruction and one was diagnosed at single lung transplant. Mosaicism with nodule(s) was the typical pattern of DIPNECH on HRCT, but one case had normal imaging despite airflow obstruction. Lung function tests showed obstructive (n=8), mixed (n=3) or normal (n=5, all group 2) physiology. Two patients underwent a bronchioalveolar lavage and showed a lymphocytosis (30%) with mild chronic bronchiolitis being seen in all biopsies. Tumourlets and associated typical carcinoids (n=9) showed weak positivity for TTF-1. Three patients had atypical carcinoids, one with MEN 1 syndrome. We conclude that DIPNECH is being increasingly recognised, probably due to an increase in the usage and accuracy of investigative imaging and increased awareness of the entity. Most cases remain stable over many years independent of the mode of presentation, although a few patients progress to severe airflow obstruction.

                  • DIPNECH
                  • Lung
                  • MEN 1 syndrome
                  • Neuroendocrine cell hyperplasia
                  • TTF-1

                  Statistics from Altmetric.com

                  Request permissions

                  If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                  Linked Articles

                  • Airwaves
                    Wisia Wedzicha